New diabetes drugs under Real-World watch: 15,000 patients enrolled
NCT ID NCT05926414
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study is observing 15,000 adults with type 2 diabetes who are starting Envlo or Envlomet SR tablets. Researchers will check how well these drugs control blood sugar (HbA1c) over 24 weeks and monitor for side effects. The goal is to see if they work safely in everyday medical practice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Enavogliflozin (Envlo tablet or Envlomet SR tablet)
- What this could lead to
- If successful, this could confirm that Envlo or Envlomet SR helps control blood sugar in type 2 diabetes patients in real-world settings.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be less reliable. It only follows patients for 24 weeks, so long-term effects are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NaRi Kim
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a heart drug tame blood sugar and weight in diabetes?
- Can a puff of insulin replace a needle for diabetes?
- Could a quick insulin shot stop Steroid-Induced blood sugar spikes?
- Can a puff of insulin replace a daily shot for diabetes?
- Could a Dairy-Rich diet tame type 2 diabetes?
- Can a traditional herbal remedy tame type 2 diabetes?